BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38554222)

  • 21. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma.
    Neves JB; Vanaclocha Saiz L; Abu-Ghanem Y; Marchetti M; Tran-Dang MA; El-Sheikh S; Barod R; Beisland C; Capitanio U; Cullen D; Klatte T; Ljungberg B; Mumtaz F; Patki P; Stewart GD; Dabestani S; Tran MGB; Bex A;
    World J Urol; 2021 Oct; 39(10):3823-3831. PubMed ID: 33851271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patients.
    Meskawi M; Sun M; Ismail S; Bianchi M; Hansen J; Tian Z; Hanna N; Trinh QD; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Mod Pathol; 2013 Aug; 26(8):1144-9. PubMed ID: 23370773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study.
    Kolar J; Llaurado AF; Ulamec M; Skenderi F; Perez-Montiel D; Alvarado-Cabrero I; Bulimbasic S; Sperga M; Tretiakova M; Osunkoya AO; Rogala J; Comperat E; Gal V; Dunatov A; Pivovarcikova K; Michalova K; Vesela AB; Slisarenko M; Strakova AP; Pitra T; Hora M; Michal M; Alaghehbandan R; Hes O
    Ann Diagn Pathol; 2022 Oct; 60():151978. PubMed ID: 35609473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
    Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
    Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
    Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
    Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
    de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of cellular morphology and three-tiered nuclear grade on progression of conventional renal cell carcinoma.
    Domonkos L; Yusenko M; Kovacs G; Peterfi L
    J Clin Pathol; 2024 Mar; 77(4):246-250. PubMed ID: 38124007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
    Baraban EG; Elias R; Lin MT; Ged Y; Zhu J; Pallavajjala A; Singla N; Lotan TL; Argani P; Eshleman JR; Epstein JI
    Mod Pathol; 2024 May; 37(5):100472. PubMed ID: 38492778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
    Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study.
    Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
    Front Public Health; 2022; 10():840525. PubMed ID: 35273943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.
    Casuscelli J; Becerra MF; Seier K; Manley BJ; Benfante N; Redzematovic A; Stief CG; Hsieh JJ; Tickoo SK; Reuter VE; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA
    Clin Genitourin Cancer; 2019 Oct; 17(5):373-379.e4. PubMed ID: 31326335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
    Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question!
    Ohashi R; Hartmann A; Martignoni G; Moch H
    Eur Urol; 2021 Jul; 80(1):e17-e18. PubMed ID: 33934927
    [No Abstract]   [Full Text] [Related]  

  • 37. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.
    Bektas S; Bahadir B; Kandemir NO; Barut F; Gul AE; Ozdamar SO
    Kaohsiung J Med Sci; 2009 Nov; 25(11):596-600. PubMed ID: 19858038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grading of renal cell carcinoma.
    Delahunt B; Eble JN; Egevad L; Samaratunga H
    Histopathology; 2019 Jan; 74(1):4-17. PubMed ID: 30565310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases From a Single Institution.
    Khor LY; Dhakal HP; Jia X; Reynolds JP; McKenney JK; Rini BI; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Sep; 40(9):1224-31. PubMed ID: 27428737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.
    Zhang ZL; Chen W; Li YH; Liu ZW; Luo JH; Lau W; Tan MH; Zhou FJ
    Chin J Cancer; 2011 Nov; 30(11):772-8. PubMed ID: 22035858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.